Abstract
This chapter will review the presentation, epidemiology, workup, and treatment modalities available to children with retinoblastoma. Current approaches include the use of systemic chemotherapy combined with adjuvant techniques to treat intraocular disease, reducing the need for external-beam radiotherapy. A multidisciplinary approach in which the expertise of pediatric oncologists, ophthalmologists, radiation oncologists, and geneticists is combined generally works best.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Readings
Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 1998;105:573–580.
Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology 1999;106:1947–1950.
Augsburger JJ, Oehlschläger U, Manzitti JE, et al. Multinational clinical and pathologic registry of retinoblastoma: Retinoblastoma International Collaborative Study report 2. Graefes Arch Clin Exp Ophthalmol 1995;233:469–475.
Bagley LJ, Hurst RW, Zimmerman RA, et al. Imaging in the trilateral retinoblastoma syndrome. Neuroradiology 1996;38:166–170.
Balmer A, Munier F, Gailloud C. Retinoma: case studies. Ophthalmic Paediatrics and Genetics 1991;12:131–137.
Damato B. Retinoblastoma. In: Damato B. Ocular Tumours: Diagnosis and Treatment. Oxford, UK: Butterworth-Heinemann; 2000:127–149.
DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000;10:255–269.
Draper GJ, Sanders BM, Brownbill PA. Patterns of risk and hereditary retinoblastoma and applications to genetic counseling. Br J Cancer 1992;66:211–219.
Ellsworth RM. Retinoblastoma: an overview. In: Blodi FC, ed. Contemporary Issues in Ophthalmology, vol 2. New York, NY: Churchill Livingstone; 1985:1–10.
Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121–1128.
Gallie BL, Budnig A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996;114:1321–1328.
Gallie BL, Phillips RA, Ellsworth RM, et al. Significance of retinoma and phthisis bulbi for retinoblastoma. Ophthalmology 1982;89:1393–1399.
Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 1997;19:428–432.
Harbour JW. Overview of Rb gene mutations in patients with retinoblastoma: implications for clinical genetic screening. Ophthalmology 1998;105:1442–1447.
Harbour JW. Retinoblastoma: pathogenesis and diagnosis. In: Char DH. Tumors of the Eye and Ocular Adnexa. Hamilton, ON, Canada: BC Decker; 2001a:253–265.
Harbour JW. Retinoblastoma: treatment. In: Char DH. Tumors of the Eye and Ocular Adnexa. Hamilton, ON, Canada: BC Decker; 2001b:266–278.
Hayden BH, Murray TG, Scott IU, et al. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule. Arch Ophthalmol 2000;118:1549–1554.
Kingston JE, Hungerford JL, Madreperla SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114:1339–1343.
Kingston JE, Hungerford JL, Plowman PN. Chemotherapy in metastatic retinoblastoma. Ophthalmic Paediatrics and Genetics 1987;8:69–72.
Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820–823.
Marcus DM, Brooks SE, Leff G, et al. Trilateral retinoblastoma: insights into histogenesis and management. Surv Ophthalmol 1998;43:59–70.
Messmer EP, Heinrich T, Höpping W, et al. Risk factors for metastasis in patients with retinoblastoma. Ophthalmology 1991;98:136–141.
Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348–1356.
Saarinen UM, Sariola H, Hovi L. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue. Am J Pediatr Hematol Oncol 1991;13:315–319.
Shields CL, De Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1330–1338.
Shields CL, Santos MCM, Diniz W, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol 1999;117:885–893.
Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999;36:8–18.
Shields CL, Shields JA, De Potter P, et al. Plaque radiotherapy in the management of retinoblastoma: use as a primary and secondary treatment. Ophthalmology 1993;100:216–224.
Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus 2000; 37:134–141.
Stallard, HB. The conservative treatment of retinoblastoma. Trans Ophthalmol Soc U K 1962;82:473–534.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Faustina, M., Herzog, C.E., Gombos, D.S. (2005). Retinoblastoma. In: Chan, K.W., Raney, R.B. (eds) Pediatric Oncology. M.D. Anderson Cancer Care Series, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-24472-3_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-24472-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24470-9
Online ISBN: 978-0-387-24472-3
eBook Packages: MedicineMedicine (R0)